RONY DEV to Antiemetics
This is a "connection" page, showing publications RONY DEV has written about Antiemetics.
Connection Strength
1.560
-
Benefits and risks of off-label olanzapine use for symptom management in cancer patients-a case report. Ann Palliat Med. 2023 May; 12(3):600-606.
Score: 0.820
-
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study. Invest New Drugs. 2022 02; 40(1):124-133.
Score: 0.740